Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 14, 2014
Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients
Sébastien Hapdey, Agathe Edet-Sanson, Pierrick Gouel, et al.
Frontiers in Medicine
|
June 29, 2019
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma
Michael Gérard, Aurélien Corroyer-Dulmont, Paul Lesueur, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 7, 2002
Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists
Philippe Giraud, Sabine Elles, Sylvie Helfre, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial
Maciej Krzakowski, Mariano Provencio, Beata Utracka-Hutka, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancer
Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2022
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 28, 2022
Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
World Journal of Urology
|
August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
Romain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity
Véronique Beckendorf, Stéphane Guérif, Elisabeth Le Prisé, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2014
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)
Pierre Vera, Sandrine Mezzani-Saillard, Agathe Edet-Sanson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 14, 2014
Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients
Sébastien Hapdey, Agathe Edet-Sanson, Pierrick Gouel, et al.
Frontiers in Medicine
|
June 29, 2019
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma
Michael Gérard, Aurélien Corroyer-Dulmont, Paul Lesueur, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 7, 2002
Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists
Philippe Giraud, Sabine Elles, Sylvie Helfre, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial
Maciej Krzakowski, Mariano Provencio, Beata Utracka-Hutka, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancer
Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2022
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 28, 2022
Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
World Journal of Urology
|
August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
Romain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity
Véronique Beckendorf, Stéphane Guérif, Elisabeth Le Prisé, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2014
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)
Pierre Vera, Sandrine Mezzani-Saillard, Agathe Edet-Sanson, et al.
Page
of 5